05.12.2017 • News

Evonik Consolidates Indian Precious Metal Catalysts

(c) Evonik
(c) Evonik

German chemical producer Evonik plans to concentrate its closed loop precious metal catalyst business in India at its integrated production site in Dombivli, near Mumbai, from the second quarter of next year.

In preparation for the new set-up effective from Apr. 1, 2018 the Essen-based company’s Indian subsidiary will dissolve its local contract manufacturing agreement partnership with Ravindra Heraeus for precious metal catalysts and refining of spent catalysts at the end of March.

For a transition period up to December 31, 2018, Evonik said it will be able to fall back on the option of contract manufacturing for precious metal catalysts at Ravindra Heraeus at Udaipur, Rajasthan, if needed.

In India, Evonik’s catalyst business is focused on high-end precious metal catalysts based on its global state-of-the-art Noblys technology. The activities also include rapid refining optimized for high precious metal yields as well as a broad range of precious metal management services for customers.

In its research and development laboratories at the Indian site, the chemical producer also offers technical services and tailored catalyst development.

Along with India, Evonik’s catalyst business is positioned globally with altogether eight system solutions sites in six countries, including Brazil, China, Germany, Japan and the US.  In addition to precious metal catalysts, it also supplies catalysts and components as well as integrated services to customers in the life sciences & fine chemicals, industrial chemicals & petrochemicals, oleochemicals and polyolefins industries.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.